Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 5.0% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours (NYSE: CC) is a chemical company recognized for its innovative practices and dedication to research. Despite encountering financial struggles, the company is actively working on strengthening its product portfolio and competitiveness.

Why is Chemours Company (The) going up?

CC stock is up 5.0% on Jun 11, 2026 16:15

  • Recent market activity saw a notable upward trend in Chemours stock (CC) following a period of declines, possibly attributed to the emphasis on scientific advancement and talent retention within the company.
  • The introduction of the "Catalyst for Scientific Excellence Award" signals a commitment to nurturing a robust research environment, paving the way for potential future innovations and product advancements that could positively influence long-term investor sentiments.
  • Resolving a pollution injunction and responding to antitrust allegations likely provided investors with a sense of assurance and adherence, contributing to the bullish market movement.
  • Despite lingering financial uncertainties, Chemours' proactive approach towards promoting its research culture and addressing legal matters may have bolstered investor confidence in the company's growth prospects over the long run.

CC Price Chart

CC Technical Analysis

CC News

Chemours Award Highlights Research Culture And Long Term Investor Considerations

Chemours (NYSE: CC) has launched its first "Catalyst for Scientific Excellence Award" to recognize internal researchers, signaling a strategic focus on its science-driven culture and talent retention. This move is presented as a data point for investors, suggesting potential long-term benefits for the company's product pipeline and competitive strength, despite current financial risks like interest payment coverage. The article encourages investors to monitor concrete outcomes linked to these awards, such as new product launches or patents, to gauge their impact.

https://www.sahmcapital.com/news/content/chemours-award-highlights-research-culture-and-long-term-investor-considerations-2026-06-05

0 News Article Image Chemours Award Highlights Research Culture And Long Term Investor Considerations

A Look at The Chemours Co (CC) After 4.2% Decline -- GF Value $1

The Chemours Co (CC) shares recently declined by 4.2%, trading at $21.67, which is 9.4% above its GF Value™ estimate of $19.81, suggesting it is overvalued. The company holds a GF Score™ of 66/100, indicating moderate potential for long-term returns, though it shows poor financial strength. A lack of insider transactions further suggests a cautious outlook for the stock.

https://www.gurufocus.com/news/8902294/a-look-at-the-chemours-co-cc-after-42-decline-gf-value-1981-vs-price-2167

1 Missing News Article Image A Look at The Chemours Co (CC) After 4.2% Decline -- GF Value $1

Federal appeals court throws out Chemours pollution injunction

A federal appeals court has overturned an injunction that required Chemours' Washington Works facility to stop exceeding its pollution limits in the Ohio River. The court found errors in the lower court's analysis of "irreparable harm," stating it improperly considered harm to the general public instead of focusing on the plaintiff's specific injury. Despite the ruling, the West Virginia Rivers Coalition plans to continue pursuing civil penalties, and Chemours stated it would continue to comply with permit limits, as it has since the initial injunction.

https://www.wtap.com/2026/06/05/federal-appeals-court-throws-out-chemours-pollution-injunction/

2 News Article Image Federal appeals court throws out Chemours pollution injunction

Attorney General Jeff Jackson Defends Antitrust Enforcement in Chemours Case

Attorney General Jeff Jackson is advocating for comprehensive antitrust enforcement in the Fourth Circuit Court of Appeals, arguing that alleged anticompetitive conduct should be evaluated as a whole, not piecemeal. He filed an amicus brief in a case involving Chemours, which is accused of illegally monopolizing the HVAC refrigerant market. Jackson emphasizes that proper enforcement of antitrust laws is crucial to protect consumers from higher prices and fewer choices and has a history of pursuing companies for anticompetitive behavior.

https://ncdoj.gov/attorney-general-jeff-jackson-defends-antitrust-enforcement-in-chemours-case/

3 News Article Image Attorney General Jeff Jackson Defends Antitrust Enforcement in Chemours Case

Chemours Award Highlights Research Culture And Long Term Investor Considerations

Chemours (NYSE:CC) has launched its first Catalyst for Scientific Excellence Award to recognize internal researchers for their contributions to innovation and knowledge sharing. This initiative signals the company's commitment to fostering a stronger science-driven culture and efficient knowledge transfer, which could enhance its product pipeline and competitive strength. While the company faces financial challenges, the award is seen as a positive cultural indicator that might attract and retain talent, potentially supporting future growth and long-term value creation.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/chemours-award-highlights-research-culture-and-long-term-inv

4 News Article Image Chemours Award Highlights Research Culture And Long Term Investor Considerations

Chemours Company (The) Price History

05.05.2026 - CC Stock was down 5.0%

  • Today's bearish movement in CC stock can be attributed to a combination of factors:
  • The appeals court overturning the ruling to stop Chemours from polluting the Ohio River may have raised concerns among investors about the company's environmental practices and potential regulatory challenges.
  • The company's recent financial performance, with a net loss in Q1 2026 and underperforming earnings compared to estimates, likely contributed to the negative sentiment and selling pressure on the stock.
  • Despite honoring distinguished researchers with a scientific excellence award, the positive news may have been overshadowed by the broader concerns regarding compliance issues and financial outlook.
  • The AI-generated analysis highlighting positive sentiment and potential gains may not have been sufficient to offset the overall negative market sentiment and uncertainties surrounding Chemours' operations and future prospects.

07.04.2026 - CC Stock was down 5.2%

  • Chemours (CC) recorded a Q1 loss of US$29 million, raising concerns about its profitability and influencing the bearish market trend.
  • Despite displaying some positive operational advancements, the stock faced a 13% decline due to the market's negative response to adjusted earnings guidance and heightened financial commitments.
  • The company's declaration of a quarterly cash dividend potentially offered some stability, but the focus on margins, revenue growth, and financial pressures contributed to the prevailing bearish outlook.
  • Observers are particularly attentive to Chemours' pricing strategies, operational efficiencies, and ability to navigate geopolitical challenges as they evaluate its future trajectory and market sentiment.

02.05.2026 - CC Stock was up 7.2%

  • Today's bullish movement in CC stock is possibly linked to a new partnership with the Wood County Technical Center. This collaboration not only boosts the company's reputation but also signals a dedication to supporting the manufacturing workforce, which could be seen positively by investors.
  • Initially, some market uncertainty may have arisen due to an amicus brief filed in the antitrust lawsuit against Chemours by attorneys general. However, the subsequent dismissal of the lawsuit, along with an appeal and a focus on thoroughly assessing monopoly claims, may have reassured investors about the company's legal position and future opportunities in the refrigerant market.
  • In summary, the positive partnership news and potential regulatory clarity post-lawsuit developments likely contributed to the bullish movement in CC stock today. These factors could be interpreted by investors as signs of growth and reliability for the company going forward.

21.04.2026 - CC Stock was down 5.2%

  • Chemours (CC) stock saw a significant decline of 8.4% today.
  • A Q1 2026 net loss of US$29 million was reported by the company, possibly contributing to the negative market reaction.
  • Despite unveiling new guidance for a profitable trajectory in 2026, concerns regarding PFAS litigation and the necessity for successful execution of the guidance appear to have overshadowed the positive outlook.
  • Ongoing legal disputes with the North Carolina Attorney General concerning environmental issues and the uncertainty surrounding the lawsuit's resolution may also be impacting investor confidence in Chemours.

30.03.2026 - CC Stock was up 5.0%

  • The significant stock price appreciation of Chemours (CC) can be attributed to multiple factors:
  • Despite differing views on its valuation, the stock has experienced a surge in price, indicating investor confidence in its future.
  • Investments by Vanguard Capital Management and Vanguard Portfolio Management have further bolstered faith in the company's growth.
  • The recent peak in stock price reflects positive momentum and investor attraction towards Chemours.
  • Concerns raised by Cumberland County about PFAS contamination pose potential risks for Chemours, potentially affecting its future stock performance.

19.04.2026 - CC Stock was down 7.3%

  • Chemours reported a Q1 net loss but issued new guidance projecting a path to profitability for the full year, leading to investor concerns and contributing to the bearish movement.
  • Despite receiving awards for energy efficiency and sustainable manufacturing initiatives, persistent concerns about PFAS litigation and the need for strong execution on new guidance continue to weigh on investor sentiment.
  • The company's CFO discussed cost reduction strategies and forecasted adjusted EBITDA, but uncertainties around PFAS-related liabilities and tariffs impact on business operations may have added to the downward pressure on the stock.
  • The industry study highlighting a path to cut automotive refrigerant emissions in Europe could have a positive long-term impact on Chemours' sustainability efforts, but the immediate market reaction seems to have been influenced more by the near-term financial outlook and litigation concerns.

15.04.2026 - CC Stock was down 5.2%

  • The bearish movement in Chemours Corporation's stock (CC) today could be attributed to several factors:
  • Despite receiving recognition for its energy efficiency initiatives and sustainable manufacturing practices, investors may have been looking for more immediate financial gains rather than long-term sustainability efforts.
  • Discussions of cost reductions and adjusted EBITDA forecasts might have raised concerns about potential challenges in achieving these targets, leading to a lack of confidence among investors.
  • The actions to cut automotive refrigerant emissions in Europe, while positive for the environment, may have raised questions about the company's future revenue streams if regulatory changes impact its products in the automotive sector.
  • The information about the number of shareholders could indicate a lack of significant new investors or institutional interest in the company, potentially signaling a lack of market confidence in CC's growth prospects.

06.04.2026 - CC Stock was down 16.0%

  • Today, Chemours experienced a decline in its stock price, possibly due to the company's failure to meet revenue expectations in Q1, reporting $1.38 billion instead of the anticipated $1.40 billion.
  • While announcing a new dividend and achieving a 52-week high were positive developments, the slight revenue miss may have raised uncertainties among investors about the company's future growth.
  • The use of AI models indicating increased downside risk at current levels might have also influenced bearish sentiment, leading some investors to cash in profits or adjust their positions cautiously.
  • The market's response appears to combine profit-taking following recent strong performance and some ambiguity surrounding Chemours' revenue outlook in the short term.

04.05.2026 - CC Stock was down 6.8%

  • The court ruling concerning water pollution raised concerns among investors, potentially signaling regulatory and environmental challenges for Chemours, leading to a decline in the stock price.
  • Despite positive sentiments from AI analysis and recognition for scientific achievements, legal troubles and regulatory issues faced by Chemours overshadowed the company’s outlook, affecting investor confidence.
  • State attorneys general involvement in an antitrust lawsuit concerning HVAC refrigerants added further uncertainty to Chemours' market standing, potentially influencing the bearish stock performance.
  • Legal battles, regulatory uncertainties, and market competition in refrigerants collectively contributed to the downward movement in Chemours' stock price.

11.05.2026 - CC Stock was up 5.0%

  • Recent market activity saw a notable upward trend in Chemours stock (CC) following a period of declines, possibly attributed to the emphasis on scientific advancement and talent retention within the company.
  • The introduction of the "Catalyst for Scientific Excellence Award" signals a commitment to nurturing a robust research environment, paving the way for potential future innovations and product advancements that could positively influence long-term investor sentiments.
  • Resolving a pollution injunction and responding to antitrust allegations likely provided investors with a sense of assurance and adherence, contributing to the bullish market movement.
  • Despite lingering financial uncertainties, Chemours' proactive approach towards promoting its research culture and addressing legal matters may have bolstered investor confidence in the company's growth prospects over the long run.

05.04.2026 - CC Stock was up 5.5%

  • CC stock hit a new 52-week high of $27.53, marking a significant 130% year-to-date increase, driven by strong investor confidence and strategic growth measures.
  • The successful $700 million debt issuance to retire existing notes and positive analyst projections regarding enhanced profitability and higher titanium dioxide EBITDA margins have further propelled the optimistic sentiment.
  • Despite concerns raised about potential overvaluation, positive market sentiment, approval of equity plans by shareholders, and the appointment of an independent auditor have all played a role in the stock's upward trend.
  • Strategic decisions, such as the endorsement of the 2026 Equity and Incentive Plan and favorable analyst reviews, are likely factors boosting investor confidence and contributing to the positive momentum in CC stock.

11.04.2026 - CC Stock was up 5.0%

  • The positive sentiment surrounding CC stock's uptrend might be linked to the completion of a Euro-denominated term loan repricing, hinting at potential cost savings for the company.
  • Notable insider stock grants were awarded to directors Courtney Mather, Mary B. Cranston, and Erin N. Kane, potentially boosting investor confidence in the company's growth trajectory.
  • The equity awards given to directors in a non-cash form indicate alignment with shareholders' interests, which could enhance investor trust in the stock.
  • In summary, a mix of favorable financial updates and insider activities likely fueled the bullish movement of CC stock during the day.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.